Published in Proc Natl Acad Sci U S A on December 01, 1986
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol (1991) 4.31
Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci U S A (1988) 3.74
In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A (1987) 3.03
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol Cell Biol (1989) 2.87
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A (1991) 2.48
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci U S A (1990) 2.36
A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol (1993) 2.18
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol (1991) 2.06
bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J (1990) 2.00
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J (1994) 1.94
Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol Cell Biol (1991) 1.68
Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol (1998) 1.68
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol Cell Biol (1994) 1.67
Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol (1989) 1.67
Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc Natl Acad Sci U S A (1993) 1.60
Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1988) 1.56
The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci U S A (1990) 1.54
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc Natl Acad Sci U S A (1991) 1.46
ABR, an active BCR-related gene. Nucleic Acids Res (1989) 1.42
Shifting paradigms: the seeds of oncogene addiction. Nat Med (2009) 1.37
Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells. Blood (2007) 1.19
Human transcription factor IIIC box B binding subunit. Proc Natl Acad Sci U S A (1994) 1.15
Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol (1988) 1.15
The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation. Mol Cell Biol (1989) 1.00
The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia. Nucleic Acids Res (1988) 0.93
Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Mol Cell Biol (1991) 0.92
Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines. Mol Cell Biol (1991) 0.89
Unique organization of the human BCR gene promoter. Nucleic Acids Res (1990) 0.89
BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets. J Virol (1993) 0.83
Retroviral vector design for gene therapy of cancer: specific inhibition and tagging of BCR-ABLp190 cells. Mol Med (1996) 0.79
Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1989) 0.78
Functional mechanisms and roles of adaptor proteins in abl-regulated cytoskeletal actin dynamics. J Signal Transduct (2012) 0.77
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59
A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36
Rapid similarity searches of nucleic acid and protein data banks. Proc Natl Acad Sci U S A (1983) 53.12
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell (1986) 42.45
Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res (1981) 18.27
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood (1975) 15.95
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature (1973) 15.28
Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol (1980) 11.28
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A (1978) 9.59
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (1985) 8.32
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
Selection of initiation sites by eucaryotic ribosomes: effect of inserting AUG triplets upstream from the coding sequence for preproinsulin. Nucleic Acids Res (1984) 5.96
Initiation of translation at internal AUG codons in mammalian cells. Nature (1984) 5.34
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell (1984) 4.78
The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell (1982) 4.66
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature (1984) 4.19
Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst (1960) 4.15
Structural organization of the bcr gene and its role in the Ph' translocation. Nature (1985) 4.08
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science (1986) 3.53
Casein kinases--multipotential protein kinases. Curr Top Cell Regul (1982) 2.85
The role of protein phosphorylation in the hormonal control of enzyme activity. Eur J Biochem (1985) 2.74
Mutation of a termination codon affects src initiation. Mol Cell Biol (1984) 2.23
A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. Proc Natl Acad Sci U S A (1980) 2.16
Initiation of translation of the cauliflower mosaic virus genome from a polycistronic mRNA: evidence from deletion mutagenesis. EMBO J (1984) 2.13
Chronic myelogenous leukemia: recent advances. Blood (1985) 1.99
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci U S A (1985) 1.94
Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol (1985) 1.92
Pattern recognition in nucleic acid sequences. II. An efficient method for finding locally stable secondary structures. Nucleic Acids Res (1982) 1.81
The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol (1986) 1.72
Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia. Nature (1986) 1.53
Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet (1984) 1.46
Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science (1984) 1.44
Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia. Proc Natl Acad Sci U S A (1986) 1.41
The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology (1985) 1.41
Multiple expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells. J Immunol (1981) 1.07
Chromosome abnormalities in human leukemia. Annu Rev Genet (1980) 1.06
Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment. Br J Haematol (1985) 0.84
The Philadelphia chromosome: a model of cancer and molecular cytogenetics. Cancer Genet Cytogenet (1986) 0.84
c-abl Oncogene and chromosome 22 "bcr" juxtaposition in chronic myelogenous leukemia. N Engl J Med (1985) 0.82
Ph1-negative chronic granulocytic leukemia: a nonentity. Am J Clin Pathol (1986) 0.80
Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet (1999) 24.24
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region. Cell (1981) 9.54
Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell (1995) 9.11
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine. Nature (1980) 6.76
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci U S A (1980) 6.73
Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc Natl Acad Sci U S A (1978) 6.38
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature (1984) 5.75
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell (1980) 5.68
Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature (1997) 5.35
Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science (1990) 5.20
Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev (1996) 5.13
Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP. Eur J Immunol (1999) 5.02
Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome. J Virol (1974) 4.84
Cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst (2001) 4.80
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell (1984) 4.78
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol (1991) 4.31
Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature (1984) 4.18
Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants. J Virol (1978) 4.06
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med (1999) 4.06
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A (1998) 3.89
Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci U S A (1982) 3.74
Differential expression of myc family genes during murine development. Nature (1986) 3.57
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science (1986) 3.53
CDKN2A mutations in multiple primary melanomas. N Engl J Med (1998) 3.52
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med (1997) 3.46
Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50. J Virol (1980) 3.30
Driving, glaucoma, and the law. BMJ (1994) 3.24
In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A (1987) 3.03
Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes. Virology (1977) 3.01
Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol (1985) 2.91
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet (2000) 2.87
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol Cell Biol (1989) 2.87
Alternative 5' exons in c-abl mRNA. Cell (1986) 2.85
A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product. Nature (1979) 2.85
Lethal effect of the Abelson murine leukemia virus transforming gene product. Cell (1981) 2.82
Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med (1994) 2.75
Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science (1996) 2.71
Dominant negative MYC blocks transformation by ABL oncogenes. Cell (1992) 2.64
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene (2000) 2.61
Retracted Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science (2001) 2.52
Structure of the murine leukemia virus envelope glycoprotein precursor. J Virol (1979) 2.51
Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface. J Virol (1979) 2.50
Leukemia and the disruption of normal hematopoiesis. Cell (1991) 2.43
Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity. Nature (1984) 2.39
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res (1999) 2.38
Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature (1983) 2.36
Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci U S A (1990) 2.36
The effect of pupil dilation with tropicamide on vision and driving simulator performance. Eye (Lond) (2000) 2.35
BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell (1991) 2.29
A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells. Cell (1987) 2.27
Structure of the Abelson murine leukemia virus genome. Cell (1979) 2.27
The impact of childhood abuse and neglect on adult mental health: a prospective study. J Health Soc Behav (2001) 2.23
Structural characteristics of some murine RNA tumor viruses studied by lactoperoxidase iodination. Proc Natl Acad Sci U S A (1973) 2.18
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. Proc Natl Acad Sci U S A (1980) 2.16
Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule. J Virol (1980) 2.16
Somatic variants of murine immunoglobulin lambda light chains. Nature (1982) 2.15
The viral and cellular forms of the Abelson (abl) oncogene. Adv Virus Res (1988) 2.10
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation (2001) 2.09
Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity (1996) 2.07
The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell (1991) 2.06
Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc Natl Acad Sci U S A (1994) 2.04
Dual expression of lambda genes in the MOPC-315 plasmacytoma. Nature (1981) 2.03
A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol (2001) 2.01
Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J Biol Chem (1997) 2.00
The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am (1999) 2.00
Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med (1998) 1.99
Murine B cell lymphopoiesis in long term culture. J Immunol Methods (1984) 1.98
Sulfhydryl group catalysis of charge transfer. Proc Natl Acad Sci U S A (1972) 1.96
The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science (1987) 1.94
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci U S A (1985) 1.94
Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity. J Virol (1984) 1.93
Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol (1996) 1.93
Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol (1985) 1.92
Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim (2000) 1.91
Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1978) 1.88
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet (1998) 1.88
v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Proc Natl Acad Sci U S A (1991) 1.86
Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation. J Virol (1980) 1.85
Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases. Proc Natl Acad Sci U S A (1997) 1.85
Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci U S A (1994) 1.83
Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential. J Virol (1981) 1.80
Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus. Cell (1977) 1.80
Impaired expansion of mouse B cell progenitors lacking Btk. Immunity (1995) 1.79
HHV-6 in AIDS. Lancet (1994) 1.76
Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science (1987) 1.76